The bears remain in control of 
ASML, with declining prices and rising volume signaling distribution pressure. The horizontal trading range around the 2024 highs looks like a classic distribution phase, leading to the current downtrend.
At the moment,ASML is testing the 0.786 Fib retracement (2021 high – 2022 low). I expect this level to fail and the downtrend to continue. My projected scenario shows a move down into the marked buy zone, which aligns with both key Fib levels and long-term channel support.
In this area, buyers may begin to absorb the previously distributed shares, setting the stage for a new accumulation phase and a potential trend reversal.
Fundamentally, ASML remains a top-tier asset with a dominant position in EUV lithography. That’s why I plan to accumulate if the buy zone is reached. If the zone fails, the next major support lies around 430.
ASML, with declining prices and rising volume signaling distribution pressure. The horizontal trading range around the 2024 highs looks like a classic distribution phase, leading to the current downtrend.At the moment,
ASML is testing the 0.786 Fib retracement (2021 high – 2022 low). I expect this level to fail and the downtrend to continue. My projected scenario shows a move down into the marked buy zone, which aligns with both key Fib levels and long-term channel support.In this area, buyers may begin to absorb the previously distributed shares, setting the stage for a new accumulation phase and a potential trend reversal.
Fundamentally, ASML remains a top-tier asset with a dominant position in EUV lithography. That’s why I plan to accumulate if the buy zone is reached. If the zone fails, the next major support lies around 430.
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.